These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways. Yan DY, Tang J, Chen L, Wang B, Weng S, Xie Z, Wu ZY, Shen Z, Bai B, Yang L. J Cell Mol Med; 2020 Feb; 24(3):2330-2341. PubMed ID: 31883297 [Abstract] [Full Text] [Related]
26. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway. Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H. Mol Cell Endocrinol; 2020 Sep 15; 515():110921. PubMed ID: 32615283 [Abstract] [Full Text] [Related]
33. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Cho SW, Yang JY, Sun HJ, Jung JY, Her SJ, Cho HY, Choi HJ, Kim SW, Kim SY, Shin CS. Bone; 2009 Jun 15; 44(6):1069-77. PubMed ID: 19254785 [Abstract] [Full Text] [Related]
35. 6-Bromoindirubin-3'-oxime promotes osteogenic differentiation of canine BMSCs through inhibition of GSK3β activity and activation of the Wnt/β-catenin signaling pathway. Zhao XE, Yang Z, Gao Z, Ge J, Wei Q, Ma B. An Acad Bras Cienc; 2019 Mar 21; 91(1):e20180459. PubMed ID: 30916158 [Abstract] [Full Text] [Related]
37. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD. Bone; 2008 Apr 21; 42(4):669-80. PubMed ID: 18294945 [Abstract] [Full Text] [Related]